Trupanion (TRUP)
(Delayed Data from NSDQ)
$31.30 USD
+0.93 (3.06%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $31.25 -0.05 (-0.16%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$31.30 USD
+0.93 (3.06%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $31.25 -0.05 (-0.16%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum C VGM
Zacks News
Zacks Industry Outlook Highlights Aflac, Unum Group and Trupanion
by Zacks Equity Research
Aflac, Unum Group and Trupanion have been highlighted in this Industry Outlook article.
3 Accident & Health Insurers to Watch as Underwriting Exposure Increases
by Tanuka De
Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of Zacks Accident and Health Insurance industry players like AFL, UNM and TRUP.
Here's Why You Should Stay Invested in Trupanion (TRUP) Stock
by Zacks Equity Research
Trupanion (TRUP) is poised to grow on its focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position
Should You Retain Trupanion (TRUP) Stock in Your Portfolio?
by Zacks Equity Research
Trupanion (TRUP) gains from a focus on pet health and well-being in the pet insurance market. Its solid balance sheet supports investment in new product development and international expansion.
Trupanion (TRUP) Rallies 27% in a Year: More Upside Left?
by Zacks Equity Research
Focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position continue to drive Trupanion (TRUP).
Aflac (AFL) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Aflac (AFL) delivered earnings and revenue surprises of 5.06% and 25.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Employers Holdings (EIG) Q1 Earnings Lag Estimates
by Zacks Equity Research
Employers Holdings (EIG) delivered earnings and revenue surprises of -2.90% and 2.60%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Trupanion (TRUP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Stocks From the Prospering Accident & Health Insurance Industry
by Tanuka De
Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of Zacks Accident and Health Insurance industry players like AFL, UNM, EIG, AMSF and TRUP.
Will Higher Expenses Hurt PRA Group's (PRAA) Q4 Earnings?
by Zacks Equity Research
PRA Group's (PRAA) fourth-quarter results are likely to reflect lower cash collections from the Americas and Australia Core and higher legal collection and net interest expenses.
Is a Beat in Store for Arch Capital (ACGL) in Q4 Earnings?
by Zacks Equity Research
Arch Capital's (ACGL) fourth-quarter results are likely to reflect better performance of the Insurance and Reinsurance segments and higher net investment income, partly offset by higher loss and loss adjustment expenses.
Will High Benefits and Expenses Affect AIG's Q4 Earnings?
by Zacks Equity Research
AIG's fourth-quarter results are likely to reflect a decline in premiums and growth in net investment income.
4 Accident & Health Insurers to Watch as Underwriting Exposure Increases
by Tanuka De
Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of the Zacks Accident and Health Insurance industry players like AFL, UNM, EIG and TRUP.
Will Unum Group's (UNM) Beat Streak Continue in Q4 Earnings?
by Zacks Equity Research
Unum Group's (UNM) fourth-quarter results are likely to reflect improved premiums and an increase in net investment income.
Best Momentum Stocks to Buy for January 8th
by Zacks Equity Research
AKYA, DRTS and TRUP made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 8, 2024.
New Strong Buy Stocks for January 8th
by Zacks Equity Research
TIMB, AKYA, DRTS, TRUP and QSG have been added to the Zacks Rank #1 (Strong Buy) List on January 8, 2024.
Virtu Financial (VIRT) Falls 1.4% Despite Q3 Earnings Beat
by Zacks Equity Research
Virtu Financial's (VIRT) Market Making revenues jump 15.5% year over year in the third quarter.
Central Garden & Pet's (CENT) TDBBS Buyout to Fuel Growth
by Zacks Equity Research
Central Garden & Pet's (CENT) acquisition of TDBBS represents a significant strategic move to strengthen its presence in the Pet space.
Does Trupanion (TRUP) Have the Potential to Rally 38.83% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 38.8% in Trupanion (TRUP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Lincoln (LNC) Q3 Earnings Miss on Lower Annuities Profits
by Zacks Equity Research
Lincoln (LNC) returns $76 million in the form of common dividends to its shareholders in the third quarter.
Resuming the Bull Market: 3 Top Ranked Stocks Investors Can Buy Now
by Ethan Feller
Following yesterday's Fed meeting, the market is ready to rally
MetLife (MET) Q3 Earnings Miss Despite Rising Investment Returns
by Zacks Equity Research
MetLife (MET) exits the third quarter with cash and cash equivalents of $14.9 billion.
Aflac's (AFL) Q3 Earnings Beat on Lower Benefits and Claims
by Zacks Equity Research
Improving productivity, contributions from platforms like network, dental and vision and group life are likely to buoy Aflac's (AFL) U.S. operations.
Down -21.83% in 4 Weeks, Here's Why Trupanion (TRUP) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Trupanion (TRUP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Can AIG Q3 Earnings Beat on Strong General Insurance Growth?
by Zacks Equity Research
AIG's third-quarter results are expected to showcase strong North America operations and growing premium rates.